Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Johnetta Blakely
L. Johnetta Blakely
Sarah Cannon Research Institute
Pathology
Chemotherapy
Medicine
Carboplatin
Figitumumab
2
Papers
241
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety analysis of regorafenib prior to selective internal radiation therapy (SIRT) using 90Y resin microspheres for the treatment (tx) of patients (pts) with refractory metastatic colorectal cancer (mCRC) with liver metastases (mets).
2017
Journal of Clinical Oncology
Andrew S. Kennedy
Dianna Shipley
L. Johnetta Blakely
Michael Brian Hemphill
Kent C. Shih
Mark Mainwaring
J. D. Peyton
John D. Zubkus
David Wright
Johanna C. Bendell
Jaswinder Singh
Show All
Source
Cite
Save
Citations (0)
Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer
2009
Journal of Clinical Oncology
Daniel D. Karp
Luis Paz-Ares
Silvia Novello
Paul Haluska
Linda L. Garland
Felipe Cardenal
L. Johnetta Blakely
Peter D. Eisenberg
Corey J. Langer
George R. Blumenschein
Faye M. Johnson
Stephanie Green
Antonio Gualberto
Show All
Source
Cite
Save
Citations (241)
1